Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stemness and immune evasion conferred by the TDO2‐AHR pathway are associated with liver metastasis of colon cancer
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 113, Issue 1, Pages 170-181
Publisher
Wiley
Online
2021-10-29
DOI
10.1111/cas.15182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- TDO2 Promotes the EMT of Hepatocellular Carcinoma Through Kyn-AhR Pathway
- (2021) Lei Li et al. Frontiers in Oncology
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- The Aryl hydrocarbon receptor mediates tobacco-induced PD-L1 expression and is associated with response to immunotherapy
- (2019) Gui-Zhen Wang et al. Nature Communications
- WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer
- (2019) Lorenzo Castagnoli et al. ONCOGENE
- Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
- (2019) Michael Platten et al. NATURE REVIEWS DRUG DISCOVERY
- Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study
- (2019) Kuniko Sunami et al. CANCER SCIENCE
- PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
- (2019) Fang Wei et al. CANCER LETTERS
- Adaptive Immune Resistance Emerges from Tumor-Initiating Stem Cells
- (2019) Yuxuan Miao et al. CELL
- Kynurenine signaling through the aryl hydrocarbon receptor maintains the undifferentiated state of human embryonic stem cells
- (2019) Takako Yamamoto et al. Science Signaling
- Controlled modelling of human epiblast and amnion development using stem cells
- (2019) Yi Zheng et al. NATURE
- ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output
- (2019) Erika Terzuoli et al. Cancers
- IDO1 in cancer: a Gemini of immune checkpoints
- (2018) Lijie Zhai et al. Cellular & Molecular Immunology
- Regulation of the Immune Response by the Aryl Hydrocarbon Receptor
- (2018) Cristina Gutiérrez-Vázquez et al. IMMUNITY
- Recent Advances in Lgr5 + Stem Cell Research
- (2018) Carly Leung et al. TRENDS IN CELL BIOLOGY
- Targeting the IDO1/TDO2–KYN–AhR Pathway for Cancer Immunotherapy – Challenges and Opportunities
- (2018) Jae Eun Cheong et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Targeting the IDO1 pathway in cancer: from bench to bedside
- (2018) Ming Liu et al. Journal of Hematology & Oncology
- Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond
- (2018) Alexander J. Muller et al. Seminars in Immunopathology
- The Link between the Multiverse of Immune Microenvironments in Metastases and the Survival of Colorectal Cancer Patients
- (2018) Marc Van den Eynde et al. CANCER CELL
- Reimagining IDO Pathway Inhibition in Cancer Immunotherapy via Downstream Focus on the Tryptophan–Kynurenine–Aryl Hydrocarbon Axis
- (2018) Brian W. Labadie et al. CLINICAL CANCER RESEARCH
- The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment
- (2018) Rahul Shinde et al. TRENDS IN IMMUNOLOGY
- A distinct role for Lgr5+ stem cells in primary and metastatic colon cancer
- (2017) Felipe de Sousa e Melo et al. NATURE
- Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
- (2017) Kiyotoshi Satoh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
- (2016) Y. Lee et al. CLINICAL CANCER RESEARCH
- Role for the Aryl Hydrocarbon Receptor and Diverse Ligands in Oral Squamous Cell Carcinoma Migration and Tumorigenesis
- (2016) E. A. Stanford et al. MOLECULAR CANCER RESEARCH
- TNIK inhibition abrogates colorectal cancer stemness
- (2016) Mari Masuda et al. Nature Communications
- A TDO2-AhR Signaling Axis Facilitates Anoikis Resistance and Metastasis in Triple-Negative Breast Cancer
- (2015) Nicholas C. D'Amato et al. CANCER RESEARCH
- Engagement of the Aryl Hydrocarbon Receptor inMycobacterium tuberculosis–Infected Macrophages Has Pleiotropic Effects on Innate Immune Signaling
- (2015) Babak Memari et al. JOURNAL OF IMMUNOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Knockdown of aberrantly upregulated aryl hydrocarbon receptor reduces tumor growth and metastasis of MDA-MB-231 human breast cancer cell line
- (2013) Gennifer D. Goode et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity of Murine Solid Tumor Models as a Defining Feature of In Vivo Behavior and Response to Immunotherapy
- (2013) Melissa G. Lechner et al. JOURNAL OF IMMUNOTHERAPY
- Induction of the Stem-like Cell Regulator CD44 by Rho Kinase Inhibition Contributes to the Maintenance of Colon Cancer-Initiating Cells
- (2012) H. Ohata et al. CANCER RESEARCH
- Ah Receptor Antagonism Represses Head and Neck Tumor Cell Aggressive Phenotype
- (2012) B. C. DiNatale et al. MOLECULAR CANCER RESEARCH
- An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor
- (2011) Christiane A. Opitz et al. NATURE
- Colon Cancer Stem Cells: Promise of Targeted Therapy
- (2010) Matilde Todaro et al. GASTROENTEROLOGY
- Aryl hydrocarbon receptor inhibition downregulates the TGF-β/Smad pathway in human glioblastoma cells
- (2009) D Gramatzki et al. ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started